Emma Gasol

External Innovation & Asset Evaluation Director at Almirall

Presenter

Emma Gasol Escuer, PhD, MBA, Director of External Innovation & Asset Evaluation at Almirall, a global biopharmaceutical company focused on medical dermatology. Seasoned pharma executive and biotech investor with 20 years’ experience spanning business development, corporate strategy, venture investing and innovation scouting across biotech and pharmaceutical companies in senior positions at Grifols, Gebro Pharma, and AdBio Partners. She has a track record of transactions ranging from early-stage research alliances to commercial licensing and acquisitions.